Abstract
As a new modality of molecular imaging, bioluminescence imaging has been widely used in tumor detection and drug evaluation. However, BLI cannot present the depth of information for internal diseases such as a liver tumor in situ or a lung tumor in situ. In this paper, we describe a bioluminescence tomography (BLT) method based on the bioluminescent intensity attenuation calibration and applied it to the early detection of liver cancer in situ. In comparison with BLT without calibration, this method could improve the reconstruction accuracy by more than 10%. In comparison with micro-computed tomography and other traditional imaging modalities, this method can detect a liver tumor at a very early stage and provide reliable location information.
© 2011 Optical Society of America
Full Article | PDF ArticleMore Like This
Junting Liu, Yabin Wang, Xiaochao Qu, Xiangsi Li, Xiaopeng Ma, Runqiang Han, Zhenhua Hu, Xueli Chen, Dongdong Sun, Rongqing Zhang, Duofang Chen, Dan Chen, Xiaoyuan Chen, Jimin Liang, Feng Cao, and Jie Tian
Opt. Express 18(12) 13102-13113 (2010)
Bin Zhang, Wanzhou Yin, Hao Liu, Xu Cao, and Hongkai Wang
Biomed. Opt. Express 9(8) 3544-3558 (2018)
Ge Wang, Wenxiang Cong, Kumar Durairaj, Xin Qian, Haiou Shen, Patrick Sinn, Eric Hoffman, Geoffrey McLennan, and Michael Henry
Opt. Express 14(17) 7801-7809 (2006)